CD3/CD19-depleted haploidentical stem cell product

CD3/CD19-depleted haploidentical stem cells · University Children's Hospital Tuebingen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD3/CD19-depleted haploidentical stem cell product, covering 2014-10-08 to 2014-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells [Phase 1, Phase 2]

See pricing